Abstract
Rationale
Methamphetamine (METH) induces hyperthermia, which is diminished with chronic treatment in a dose-dependent manner. Our objective was to determine whether the temperature responses produced by a chronic, escalating-dose METH regimen and a chronic, 5.0 mg/kg dose regimen.
Methods
Rats received pretreatment injections of saline, 5.0 mg/kg METH, 10.0 mg/kg METH (second comparison group), or an escalating-METH regimen (2–9 mg/kg) for 12 days. On day 13, all four groups were challenged with 10.0 mg/kg METH. Temperature measurements were made telemetrically at 24°C ambient temperature.
Results
Escalating pretreatment produced hyperthermia; with successive exposures, the hyperthermic peak shifted to the right. The 5.0-mg/kg-pretreatment group initially showed no change in temperature at 60 min post-treatment but developed hypothermia at 60 min with chronic treatment; at 3 h post-treatment, significant hyperthermia was present and did not diminish with chronic treatment. After the 10.0-mg/kg-METH challenge, the saline-pretreatment group was hyperthermic, and the 10.0-mg/kg-pretreatment group was hypothermic; the 5.0 mg/kg and escalating pretreatment groups were intermediate and were not different from each other. At 3 h post-challenge, no group differences were apparent. Dopamine (DA) and serotonin (5-HT) were not depleted when measured 2 weeks after treatment ended.
Conclusions
(1) Escalating and 5.0-mg/kg regimens produced different temperature profiles during the 12-day pretreatment period but a similar diminished response to the 10.0-mg/kg-METH challenge on day 13. (2) The diminished temperature responses with chronic treatment occurred in the absence of long-term DA and 5-HT depletions.
Similar content being viewed by others
References
Albers DS, Sonsalla PK (1995) Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J Pharmacol Exp Ther 275:1104–1114
Bowyer JF, Davies DL, Schmued L, Broening HW, Newport GD, Slikker W, Holson RR (1994) Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther 268:1571–1580
Bowyer JF, Tank AW, Newport GD, Slikker W, Ali SF, Holson RR (1992) The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J Pharmacol Exp Ther 260:817–824
Chang L, Alicata D, Ernst T, Volkow N (2007) Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 102 (Suppl):16–32
Chang L, Cloak C, Patterson K, Grob C, Miller EN, Ernst T (2005) Enlarged striatum in abstinent methamphetamine abusers: a possible compensatory response. Biol Psychiatry 57:967–974
Chang L, Ernst T, Speck O, Patel H, DeSilva M, Leonido-Yee M, Miller EN (2002) Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users. Psychiatry Res 114:65–79
Cho AK, Melega WP (2002) Patterns of methamphetamine abuse and their consequences. J Addict Dis 21:21–34
Cho AK, Melega WP, Kuczenski R, Segal DS (2001) Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse. Synapse 39:161–166
Danaceau JP, Deering CE, Day JE, Smeal SJ, Johnson-Davis KL, Fleckenstein AE, Wilkins DG (2007) Persistence of tolerance to methamphetamine-induced monoamine deficits. Eur J Pharmacol 559:46–54
Duffy PH, Feuers RJ, Leakey JA, Nakamura K, Turturro A, Hart RW (1989) Effect of chronic caloric restriction on physiological variables related to energy metabolism in the male Fischer 344 rat. Mech Ageing Dev 48:117–133
Duffy PH, Leakey JE, Pipkin JL, Turturro A, Hart RW (1997) The physiologic, neurologic, and behavioral effects of caloric restriction related to aging, disease, and environmental factors. Environ Res 73:242–248
Gordon CJ (1990) Thermal biology of the laboratory rat. Physiol Behav 47:963–991
Gordon CJ (1993) Temperature regulation in laboratory rodents. Cambridge University Press, New York
Gygi MP, Gygi SP, Johnson M, Wilkins DG, Gibb JW, Hanson GR (1996) Mechanisms for tolerance to methamphetamine effects. Neuropharmacology 35:751–757
Hinson RE, Streather A, Cosburn G (1991) The effects of conditioning with amphetamine on the thermic effects of amphetamine and pentobarbital. Prog Neuropsychopharmacol Biol Psychiatry 15:841–850
Johnson-Davis KL, Fleckenstein AE, Wilkins DG (2003) The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity. Eur J Pharmacol 482:151–154
Johnson-Davis KL, Hanson GR, Keefe KA (2002) Long-term post-synaptic consequences of methamphetamine on preprotachykinin mRNA expression. J Neurochem 82:1472–1479
Keppel G (1991) Design and analysis: a researcher’s handbook. Prentice Hall, Englewood Cliffs, NJ
Lewander T (1971) A mechanism for the development of tolerance to amphetamine in rats. Psychopharmacologia 21:17–31
Miller DB, O'Callaghan JP (2003) Elevated environmental temperature and methamphetamine neurotoxicity. Environ Res 92:48–53
Myles BM, Jarrett LA, Broom SL, Speaker HA, Sabol KE (2008) The effects of methamphetamine on core body temperature in the rat Part 1: chronic treatment and ambient temperature. Psychopharmacology DOI 10.1007/s00213-007-1061-z
NRC (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington, D.C.
O'Callaghan JP, Miller DB (1994) Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 270:741–751
Phelps GI, Speaker HA, Sabol KE (2005) Effects of methamphetamine on core temperature and spontaneous behavior in rats. Paper presented at the Society for Neuroscience, Washington, D.C.
Poulos CX, Cappell H (1991) Homeostatic theory of drug tolerance: a general model of physiological adaptation. Psychol Rev 98:390–408
Riddle EL, Kokoshka JM, Wilkins DG, Hanson GR, Fleckenstein AE (2002) Tolerance to the neurotoxic effects of methamphetamine in young rats. Eur J Pharmacol 435:181–185
Robinson TE, Jurson PA, Bennett JA, Bentgen KM (1988) Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats. Brain Res 462:211–222
Sabol KE, Richards JB, Yung K (2000) The effects of high-dose methamphetamine in the aging rat: differential reinforcement of low-rate 72-s schedule behavior and neurochemistry. J Pharmacol Exp Ther 294:850–863
Sabol KE, Roach JT, Broom SL, Ferreira C, Preau MM (2001) Long-term effects of a high-dose methamphetamine regimen on subsequent methamphetamine-induced dopamine release in vivo. Brain Res 892:122–129
Schmidt CJ, Sonsalla PK, Hanson GR, Peat MA, Gibb JW (1985) Methamphetamine-induced depression of monoamine synthesis in the rat: development of tolerance. J Neurochem 44:852–855
Segal DS, Kuczenski R (1997) An escalating dose “binge” model of amphetamine psychosis: behavioral and neurochemical characteristics. J Neurosci 17:2551–2566
Simon SL, Domier CP, Sim T, Richardson K, Rawson RA, Ling W (2002) Cognitive performance of current methamphetamine and cocaine abusers. J Addict Dis 21:61–74
Thompson PM, Hayashi KM, Simon SL, Geaga JA, Hong MS, Sui Y, Lee JY, Toga AW, Ling W, London ED (2004) Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 24:6028–6036
Thornhill JA, Hirst M, Gowdey CW (1977) Variability in development of tolerance to repeated injections of low doses of dl-amphetamine in rats. Can J Physiol Pharmacol 55:1170–1178
Volkow ND, Chang L, Wang GJ, Fowler JS, Leonido-Yee M, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Logan J, Wong C, Miller EN (2001) Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 158:377–382
Wagner GC, Ricaurte GA, Seiden LS, Schuster CR, Miller RJ, Westley J (1980) Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res 181:151–160
Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ (1996) Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nature Med 2:699–703
Acknowledgment
The authors thank Biomedical Research Internship, NIH PHS IR25 GM55379.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Myles, B.J., Sabol, K.E. The effects of methamphetamine on core body temperature in the rat—Part 2: an escalating regimen. Psychopharmacology 198, 313–322 (2008). https://doi.org/10.1007/s00213-007-1060-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-007-1060-0